Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development and characterization of a novel cationic PEGylated niosome-encapsulated forms of doxorubicin, quercetin and siRNA for the treatment of cancer by using combination therapy
Mahdie Hemati, Fateme Haghiralsadat, Fatemeh Yazdian, et al.
Artificial Cells Nanomedicine and Biotechnology (2018) Vol. 47, Iss. 1, pp. 1295-1311
Open Access | Times Cited: 89

Showing 1-25 of 89 citing articles:

Current advances in niosomes applications for drug delivery and cancer treatment
Ali Moammeri, Masoumeh Mirzaei Chegeni, Hamidreza Sahrayi, et al.
Materials Today Bio (2023) Vol. 23, pp. 100837-100837
Open Access | Times Cited: 64
In vitro cytotoxicity assay of D-limonene niosomes: an efficient nano-carrier for enhancing solubility of plant-extracted agents
Masoud Torkzadeh‐Mahani, MohammadReza Hajizadeh, Haniyeh Maleki, et al.
Research in Pharmaceutical Sciences (2019) Vol. 14, Iss. 5, pp. 448-448
Open Access | Times Cited: 113
A concise review on cancer treatment methods and delivery systems
Elham Bidram, Yasaman Esmaeili, Hadi Ranji‐Burachaloo, et al.
Journal of Drug Delivery Science and Technology (2019) Vol. 54, pp. 101350-101350
Closed Access | Times Cited: 107
Ameliorating quercetin constraints in cancer therapy with pH-responsive agarose-polyvinylpyrrolidone -hydroxyapatite nanocomposite encapsulated in double nanoemulsion
Amirmasoud Samadi, Mehrab Pourmadadi, Fatemeh Yazdian, et al.
International Journal of Biological Macromolecules (2021) Vol. 182, pp. 11-25
Open Access | Times Cited: 97
A new formulation of hydrophobin-coated niosome as a drug carrier to cancer cells
Mahmood Barani, Mohammad Mirzaei, Masoud Torkzadeh‐Mahani, et al.
Materials Science and Engineering C (2020) Vol. 113, pp. 110975-110975
Closed Access | Times Cited: 87
Progress in Natural Compounds/siRNA Co-delivery Employing Nanovehicles for Cancer Therapy
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, et al.
ACS Combinatorial Science (2020) Vol. 22, Iss. 12, pp. 669-700
Open Access | Times Cited: 84
Cationic Niosomes as Non-Viral Vehicles for Nucleic Acids: Challenges and Opportunities in Gene Delivery
Santiago Grijalvo, Gustavo Puras, Jon Zárate, et al.
Pharmaceutics (2019) Vol. 11, Iss. 2, pp. 50-50
Open Access | Times Cited: 80
Quercetin and Its Nano-Scale Delivery Systems in Prostate Cancer Therapy: Paving the Way for Cancer Elimination and Reversing Chemoresistance
Yaseen Hussain, Sepideh Mirzaei, Milad Ashrafizadeh, et al.
Cancers (2021) Vol. 13, Iss. 7, pp. 1602-1602
Open Access | Times Cited: 66
Lipid nanovesicles for biomedical applications: ‘What is in a name’?
Alexsandra Conceição Apolinário, Leon Hauschke, Jessica Ribeiro Nunes, et al.
Progress in Lipid Research (2021) Vol. 82, pp. 101096-101096
Closed Access | Times Cited: 64
A functionalized graphene oxide with improved cytocompatibility for stimuli-responsive co-delivery of curcumin and doxorubicin in cancer treatment
Fatemeh Yaghoubi, Najmeh Sadat Hosseini Motlagh, Seyed Morteza Naghib, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 57
Overcoming doxorubicin resistance in cancer: siRNA-loaded nanoarchitectures for cancer gene therapy
Mahshid Deldar Abad Paskeh, Hamidreza Saebfar, Mahmood Khaksary Mahabady, et al.
Life Sciences (2022) Vol. 298, pp. 120463-120463
Open Access | Times Cited: 51
Nanomaterials loaded with Quercetin as an advanced tool for cancer treatment
Carlos Caro, Mehrab Pourmadadi, Mohammad Mahdi Eshaghi, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 78, pp. 103938-103938
Closed Access | Times Cited: 43
Fabrication of a Dual-Drug-Loaded Smart Niosome-g-Chitosan Polymeric Platform for Lung Cancer Treatment
Atefeh Zarepour, Abdurrahim Can Egil, Melike Çokol Çakmak, et al.
Polymers (2023) Vol. 15, Iss. 2, pp. 298-298
Open Access | Times Cited: 25
Folic acid-functionalized PEGylated niosomes co-encapsulated cisplatin and doxoribicin exhibit enhanced anticancer efficacy
Mona Safari Sharafshadeh, Farzaneh Tafvizi, Parvin Khodarahmi, et al.
Cancer Nanotechnology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Multifunctional stimuli-responsive niosomal nanoparticles for co-delivery and co-administration of gene and bioactive compound: In vitro and in vivo studies
Najmeh Alsadat Abtahi, Seyed Morteza Naghib, Sina Jafari Ghalekohneh, et al.
Chemical Engineering Journal (2021) Vol. 429, pp. 132090-132090
Closed Access | Times Cited: 48
In-Vitro Application of Magnetic Hybrid Niosomes: Targeted siRNA-Delivery for Enhanced Breast Cancer Therapy
Viktor Maurer, Selin Altin, Didem Ag Seleci, et al.
Pharmaceutics (2021) Vol. 13, Iss. 3, pp. 394-394
Open Access | Times Cited: 46
A novel delivery of curcumin by the efficient nanoliposomal approach against Leishmania major
Ali Fattahi Bafghi, Bibi Fatemeh Haghirosadat, Fatemeh Yazdian, et al.
Preparative Biochemistry & Biotechnology (2021) Vol. 51, Iss. 10, pp. 990-997
Closed Access | Times Cited: 46
Lipid-Based Nanovesicular Drug Delivery Systems
Tania Limongi, Francesca Susa, Monica Marini, et al.
Nanomaterials (2021) Vol. 11, Iss. 12, pp. 3391-3391
Open Access | Times Cited: 43
Evaluation of anti-cancer and anti-metastatic effects of folate-PEGylated niosomes for co-delivery of letrozole and ascorbic acid on breast cancer cells
Mahsa Bourbour, Nazanin Khayam, Hassan Noorbazargan, et al.
Molecular Systems Design & Engineering (2022) Vol. 7, Iss. 9, pp. 1102-1118
Closed Access | Times Cited: 28
Recent advances and futuristic potentials of nano-tailored doxorubicin for prostate cancer therapy
Rana Sawpari, Sovan Samanta, Jhimli Banerjee, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 81, pp. 104212-104212
Closed Access | Times Cited: 21
Reduction of Doxorubicin-Induced Cardiotoxicity by Co-Administration of Smart Liposomal Doxorubicin and Free Quercetin: In Vitro and In Vivo Studies
Hamidreza Dorostkar, Bibi Fatemeh Haghiralsadat, Mahdie Hemati, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1920-1920
Open Access | Times Cited: 18
Enhancing siRNA cancer therapy: Multifaceted strategies with lipid and polymer-based carrier systems
Nazgol Karimi Dastgerdi, Nazanin Karimi Dastgerdi, Hulya Bayraktutan, et al.
International Journal of Pharmaceutics (2024) Vol. 663, pp. 124545-124545
Open Access | Times Cited: 6
The combined administration of parthenolide and ginsenoside CK in long circulation liposomes with targeted tLyp-1 ligand induce mitochondria-mediated lung cancer apoptosis
Xin Jin, Jianping Zhou, Zhenhai Zhang, et al.
Artificial Cells Nanomedicine and Biotechnology (2018) Vol. 46, Iss. sup3, pp. 931-942
Open Access | Times Cited: 48
Role of flavonoids against adriamycin toxicity
María D. Navarro‐Hortal, Alfonso Varela‐López, José M. Romero‐Márquez, et al.
Food and Chemical Toxicology (2020) Vol. 146, pp. 111820-111820
Closed Access | Times Cited: 44
Nanosized paclitaxel-loaded niosomes: formulation, in vitro cytotoxicity, and apoptosis gene expression in breast cancer cell lines
Bahareh Pourmoghadasiyan, Fatemeh Tavakkoli, Farzaneh Mahmoudi Beram, et al.
Molecular Biology Reports (2022) Vol. 49, Iss. 5, pp. 3597-3608
Closed Access | Times Cited: 24
Page 1 - Next Page

Scroll to top